MyoCycle FES System

临床试验

计划入组 30 人 · 首次发布于 2016 年 4 月 6 日

进行中（未招募）

NCT05088785

Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast Cancer

计划入组 15 人 · 首次发布于 2021 年 10 月 22 日

撤回

NCT04821635

Effects of FES-Rowing in Neurological Disorders (FES-ROW)

计划入组 35 人 · 首次发布于 2021 年 3 月 29 日

药物

查看全部 1031 →

C213 Microneedle System

drug delivery system

Small Molecule

Approved

Fluoroestradiol F-18

相关疾病：Metastatic Estrogen Receptor Positive Breast Cancer, Recurrent Estrogen Receptor Positive Breast Cancer

C₁₈H₂₃FO₂

机构

查看全部 461 →

Ryder System

United States

GOSHEN HEALTH SYSTEM

United States

MEMORIAL HEALTHCARE SYSTEM

United States

资讯

查看全部 9948 →

去年

FDA Grants 510(k) Clearance for ReWalk 7 Exoskeleton for Spinal Cord Injury Patients

去年

Lifeward Partners with CorLife to Expand Workers' Compensation Access to ReWalk Exoskeleton

去年

临床试验

Multi-pad FES System for Drop Foot Treatment

Dynamic and Test-retest Whole Body [18F]FES PET Imaging in Patients With Metastatic ER+ Breast Cancer

Effects of FES-Rowing in Neurological Disorders (FES-ROW)

药物

C213 Microneedle System

drug delivery system

Fluoroestradiol F-18

机构

Ryder System

GOSHEN HEALTH SYSTEM

MEMORIAL HEALTHCARE SYSTEM

资讯

FDA Grants 510(k) Clearance for ReWalk 7 Exoskeleton for Spinal Cord Injury Patients

Lifeward Partners with CorLife to Expand Workers' Compensation Access to ReWalk Exoskeleton

Quanta's Home Hemodialysis System Receives FDA Clearance, Expanding Access to High-Flow Dialysis